Newsletter May 2021 No.203
Top News
JPMA Presidents Press Conference
On March 23, 2021, the JPMA President's Press Conference was held at the Nihonbashi Life Science Hub (Chuo-ku, Tokyo). JPMA Chairman Joji Nakayama explained the "JPMA Policy Proposal 2021" and other topics. 42 members of the press attended the press conference (22 at the venue and 20 watching via webcast), and questions were actively exchanged on the day.
Topics
- The 32nd JPMA Policy Seminar" Held Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era
- JPMA Media Forum" was held on the theme "What is a Vaccine? -In the wake of the Corona Disaster, learn about vaccines once again" - "2021 Life Science IP Policy Seminar
- The 2021 Life Science IP Forum was held, with the theme "How to Handle IP Rights in Response to Pandemics, Including COVID-19
- JPMA Media Forum" was held under the theme "Reconsidering the Various Values of Pharmaceuticals: What Contributions to Society are Expected from Pharmaceuticals?
- Workshop for Persons Responsible for Product Information Overview and Management and for Practical Responsibility in FY2020" was held.
- Held the "FY2020 Meeting of Compliance Managers and Managers in Charge of Compliance Management
Policy Research Institute
From JPMA
From the "JPMA Press Conference